The initiative is being led through the Bank’s CSR programme, Parivartan, in partnership with the Indian Cancer Society
The Eugene facility, with more than 20 years of history, houses a 16,000-square-foot R&D lab and a newly constructed 30,000-square-foot manufacturing facility
The launch of PatroLab is a pivotal milestone, marking a paradigm shift in biologics development and manufacturing
The researchers removed a chemical group commonly used in previous NK1R drugs and replaced it with a novel molecular scaffold
The FDA also noted that current prescribing information for GLP-1 RAs already includes warnings about the risk of suicidal thoughts
Iktos will deploy its AI-driven tools to accelerate the identification of optimized small-molecule candidates against a currently undisclosed oncology target
The integration unifies brand and field strategy, drives executional alignment, and delivers immediate impact measurement
The therapy is mutation-agnostic and aims to overcome limitations of existing EGFR-targeting drugs by concentrating degradation in tumors while sparing healthy tissue
The multimillion-dollar facility combines discovery and early-phase scale-up capabilities with R&D labs and two pilot plants
KRAS G12C-mutant advanced or metastatic nonsquamous non-small cell lung cancer
Subscribe To Our Newsletter & Stay Updated
